Pfizer – Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin America

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within unit

Memorial Deadline: Monday 27th, February 2023

External Deadline: Monday 6th, March 2023


Please note: this competition is for applicants who are based in Latin America, Canadian researchers may be eligible to apply as a co-applicant. Please view the RFP and contact Pzifer with inquiries.

Pfizer Global Medical Grants (GMG) support the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with our medical and/or scientific strategies.

Pfizer GMG in collaboration with Conquer Cancer, the ASCO Foundation’s through its EveryGrant® program, are launching a competitive grant program to offer a quality improvement grant funding opportunity to improve the quality of care and address inequities for metastatic breast cancer (mBC) patients in Latin America. This publicly posted Request for Proposal (RFP) provides detail regarding a general area of interest, sets timelines for review and approval, and uses an Expert Review Panel to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the RFP.

For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.


Date RFP Issued: January 18, 2023

Geographic Scope: Latin America

Clinical Area: Oncology – Metastatic Breast Cancer

Link to full RFP: Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin America

Application Due Date: March 6, 2023

Specific Area of Interest: The goal of this program is to improve the quality of mBC patient care by understanding and addressing gaps in the care that contribute to disparities in mBC patient outcomes in Latin America. These may include:

  • Gaps in clinical practice, such as the ability or competencies of the health care professionals themselves, the abilities or competencies of the systems in which they work to promote or allow proper management, or other factors related to the external environment or patient population.
  • Gaps in patient education, including factors that contribute to delays in seeking care and impediments to shared decision making.
  • Gaps in the coordination of mBC patient care across the healthcare system, including primary care and the utilization of patient navigation.
  • Gaps in real world evidence needed to diagnose the contributors to disparities in care.

This RFP seeks to provide funding to projects that are aimed at addressing these and other relevant gaps, ultimately helping health care providers deliver the best treatment to each patient at the optimal time.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: January 19, 2023